Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

KLA Corporation (KLAC-RM)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
KLA Corp historical data, for real-time data please try another search
28,142.00 0.00    0.00%
22/02 - Real-time Data. Currency in RUB ( Disclaimer )
Type:  Equity
Market:  Russia
ISIN:  US4824801009 
  • Volume: 0
  • Bid/Ask: 28,126.00 / 28,208.00
  • Day's Range: 27,847.00 - 28,142.00
KLA Corp 28,142.00 0.00 0.00%

NASDAQ:KLAC-RM Financials

 
A brief overview of the NASDAQ:KLAC financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of KLA over time.

KLA Corporation reported earnings results for the third quarter and nine months ended March 31, 2024. For the third quarter, the company reported revenue was USD 2,359.83 million compared to USD 2,432.61 million a year ago. Net income was USD 601.54 million compared to USD 697.84 million a year ago. Basic earnings per share from continuing operations was USD 4.46 compared to USD 5.06 a year ago. Diluted earnings per share from continuing operations was USD 4.43 compared to USD 5.03 a year ago.For the nine months, revenue was USD 7,243.51 million compared to USD 8,140.92 million a year ago. Net income was USD 1,925.45 million compared to USD 2,702.62 million a year ago. Basic earnings per share from continuing operations was USD 14.2 compared to USD 19.26 a year ago. Diluted earnings per share from continuing operations was USD 14.11 compared to USD 19.16 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

KLAC-RM Income Statement

Gross margin TTM 59.57%
Operating margin TTM -
Net Profit margin TTM -
Return on Investment TTM -
 Total Revenue  Net Income
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Total Revenue 2359.83 2486.73 2396.96 2355.14
Gross Profit 1366.75 1509.98 1450.06 1392.19
Operating Income 808.88 952.32 899.21 821.31
Net Income 601.54 582.53 741.38 684.65

KLAC-RM Balance Sheet

Quick Ratio MRQ -
Current Ratio MRQ 2.14
LT Debt to Equity MRQ -
Total Debt to Equity MRQ -
 Total Assets  Total Liabilities
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Total Assets 14957.29 14280.5 14136.84 14072.36
Total Liabilities 11862.4 11236.79 11146.62 11152.6
Total Equity 3094.88 3043.71 2990.22 2919.75

KLAC-RM Cash Flow Statement

Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow  20.41%
 Cash  Net Change in Cash
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 909.98 622.24 883.74 959.12
Cash From Investing Activities -858.05 -88.48 -391.67 -74.48
Cash From Financing Activities 138.92 -590.92 -705.16 -511.32
Net Change in Cash 183.11 -46.52 -216.3 359.35
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

KLAC Comments

Write your thoughts about KLA Corp
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Shaun Webb
Shaun Webb Jan 27, 2023 7:28AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Big drop today early, buy and hold for a long term winner, be patient as it’s US sanctions on China for now
Rich Rich
Rich Rich Mar 04, 2022 9:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It is the best stock
Jeff Bailey
JeffB Oct 27, 2021 4:23PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
KLAC $340.57 @ Close! (Earnings)
Kris Lodovice
Kris Lodovice Apr 29, 2021 4:12PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Can u tell me more about this
Jesus Gonzalez
Jesus Gonzalez Jan 21, 2021 10:12AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Semiconductors are at an all time high in shortage so any Semi is gold.lock company all year.for sure +profit by the end.
Duane Goodson
Duane Goodson Jan 05, 2021 2:10PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
RDGL approval or denial by Jan 16 by the FDA for breakthrough designation for their tumor fighting drug
Holandês Ferreira
Holandês Ferreira Nov 25, 2020 3:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Can anyone tell me if the YATSEN Ticket ysg is a good bet. It entered the IPO Thursday and is $ 17 now.
Charles Milani
Charles Milani Aug 19, 2020 9:17AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think he meant Navellier ? Lol
Perry Huyck
Perry Huyck Aug 10, 2020 7:36PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Navalier stock
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email